Genomics
1 Transcripts
| WormMine ID | Sequence Name | Length (nt) | Chromosome Location |
|---|---|---|---|
| Transcript:F54F12.3 | F54F12.3 |
223
 |
III: 13056379-13056601 |
Other
10 Allele
| Public Name |
|---|
| gk963887 |
| gk963904 |
| gk963552 |
| gk545313 |
| gk899021 |
| gk963763 |
| gk963762 |
| gk652562 |
| WBVar00567823 |
| WBVar01579503 |
1 Chromosome Location
|
Feature . Primary Identifier |
Start | End | Strand |
|---|---|---|---|
| WBGene00195333 | 13056379 | 13056601 | 1 |
2 Expression Clusters
| Regulated By Treatment | Description | Algorithm | Primary Identifier |
|---|---|---|---|
| Transcripts that showed significantly increased expression in animals after 24 hour exposure to 100ug per ml silica nanoparticles (SiNPs). | The random variance model (RVM)t-test was applied toidentify differentially expressed mRNAs and miRNAsbetween the SiNPs-treated group and the control group. P-value <0.05 and fold change (FC) >1.5 were considered as the threshold screening between the SiNP-treated groupand the control group. | WBPaper00060100:SiNP_upregulated_mRNA | |
| Transcripts of noncoding genes that showed significantly increased expression in muscle. | DESeq2 (version 1.24.0). Transcripts with a false-discovery rate adjusted p-value less than 0.05 were considered significantly differentially expressed. | WBPaper00062325:muscle_enriched_noncoding-RNA |
1 Upstream Intergenic Region
| WormBase ID | Name | Sequence Name | Length (nt) | Chromosome Location | Organism |
|---|---|---|---|---|---|
| intergenic_region_chrIII_13055443..13056378 | 936 | III: 13055443-13056378 | Caenorhabditis elegans |
